Cargando…
A pretreatment transcriptomic signature that predicts outcomes of immunotherapy in melanoma
Identifying indicators of immunotherapy response are key to clinical treatment decisions. To date, immunotherapy is most widely used in melanoma because of its higher tumor mutation burden compared to other cancer types. However, less than half of melanoma patients can benefit from immune checkpoint...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813707/ https://www.ncbi.nlm.nih.gov/pubmed/36619423 http://dx.doi.org/10.1016/j.heliyon.2022.e12648 |